Animal vaccines market

Q: Which is the prominent region in the market?

North America is the prominent region in the market. Read more

Animal Vaccines Market, by Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines), by Application (Companion Animal, Livestock Animal, Poultry, and Aquaculture), by Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Request Free Sample

Mar 2022
CMI4989
180 Pages
Excel & Pdf
Pharmaceutical

Summary

Vaccination enhances health of animals, thus improving their life expectancies. Veterinary vaccines are available for diseases such as rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant, as it impacts the supply of dairy products, meat, and other poultry products.

Vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, and subunit and DNA vaccines. Veterinary vaccines impact animal health and production quality and also ensure good health of general human population through consumption of various food procured from animals.

Global Animal Vaccines Market - Impact of the Coronavirus (COVID-19) Pandemic

The rapid spread of COVID-19 across the globe is posing a challenge for veterinary healthcare systems worldwide. According to data published by the Centers for Disease Control & Protection (CDC) in November 2021, the risk of animals spreading SARS-CoV-2, the virus that causes COVID-19, is low. Currently, there is no evidence that animals play a significant role in spreading SARS-CoV-2. Due to social distancing policies, most of the veterinary visits are done through telemedicine medium such as video calling from smart phones or tablet devices. For instance, in April 2020, Boehringer Ingelheim U.K. collaborated with VetHelpDirect, that offered all U.K. veterinary practices free access to an online video consultation platform for a period of three months during the pandemic. By offering an alternative to face-to-face consultation, the online platform is a means of continuing care for animals while protecting both clients and staff from the spread of COVID-19

Veterinary research centers are focused on developing a COVID-19 vaccine for animals as a preventive measures. For instance, in June 2020, the Indian Veterinary Research Institute (IVRI), announced plans of developing a vaccine and diagnostic kits, and study the transmission dynamics of COVID-19 in pets and wild animals. Moreover, this project will be carried out in collaboration with IIT-Roorkee, India.

Furthermore, in the near future, global animal vaccines market is expected witness growth, owing to the increasing demand for vaccinations for animals. Following the re-opening of manufacturing units, demand and supply are projected to meet expectations of customers whose pet vaccine schedules were delayed due to the pandemic.

The global animal vaccines market is estimated to be valued at US$ 7,119.7 Mn in 2021, and is expected to exhibit a CAGR of 6.6% over the forecast period (2021-2028).

Figure 1: Global Animal Vaccines Market Share (%) Analysis, by Product Type, 2021

Increasing number of R&D initiatives is the major factor that is expected to drive the market growth over the forecast period.

Market players are engaged in conducting research projects to help understand viral diseases, in order to discover vaccination in order to prevent animals from various diseases. For instance, in June 2018, Regeneron Pharmaceuticals, Inc. and Zoetis, Inc. announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

Increasing Product Launches and Approvals

Market players are focusing on launching generic versions of opioid medications, which is expected to augment the market growth over the forecast period. For instance, in May 2020, MSD Animal Health, a division of Merck & Co., Inc., launched NOBIVAC Myxo-RHD PLUS vaccine to reduce mortality and clinical signs of the two most common viral diseases in rabbits: myxomatosis and rabbit haemorrhagic disease (RHD) caused by both classic (RHDV1) and variant (RHDV2) strains.

Animal Vaccines Market Report Coverage

Report Coverage	Details
Base Year:	2020	Market Size in 2021:	US$ 7,119.7 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2021 to 2028
Forecast Period 2021 to 2028 CAGR:	6.6%	2028 Value Projection:	US$ 11,156.3 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines By Application: Companion Animal, Livestock Animal, Poultry, Aquaculture By Distribution Channel: Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others
Companies covered:	Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó
Growth Drivers:	Increasing number of R&D initiatives Increasing product launches
Restraints & Challenges:	High storage costs and complex manufacturing methodology of vaccines

Global Animal Vaccines Market – Restraints

Proper vaccine storage and handling is important factor in preventing and eradicating various common vaccine-preventable diseases. Yet, each year, storage and handling errors result in revaccination of several pet animals and significant financial loss due to wasted vaccines. Failure to store and handle vaccines properly can reduce vaccine potency, resulting in inadequate immune responses in pet animals and poor protection against diseases, which is anticipated to hinder the market growth.

Global Animal Vaccines Market – Regional Analysis

On the basis of region, the global animal vaccines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global animal vaccines market over the forecast period, owing to increasing initiatives by private and government organizations related to animal vaccination. For instance, in January 2020, the U.S. Department of Agriculture’s (U.S.DA) Animal and Plant Health Inspection Service (APHIS) announced to award US$ 10.2 million to support disease prevention and emergency response training, and to develop the National Animal Vaccine and Veterinary Countermeasures Bank (NAVVCB).

Figure 2: Global Animal Vaccines Market Value (US$ Mn), by Region, 2021

Global Animal Vaccines Market – Competitive Landscape

Major players operating in the global animal vaccines market include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó.

Table of Content

Table of Contents

*Browse 28 market data tables and 78 figures on "Animal Vaccines Market” - Global forecast to 2028

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What will be the compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?

The global animal vaccines market is expected to exhibit a CAGR of 6.6% during the forecast period (2021-2028).

What is the estimated market size of the market in 2021?

The market is estimated to be valued at US$ 7,119.7 Mn in 2021.

Which are the prominent players operating in the market across the globe?

Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó are some of the prominent players operating in the market.

What are the growth estimates for the market till 2028?

The market is expected to be valued at US$ 11,156.3 Mn in 2028.

Which is the prominent region in the market?

North America is the prominent region in the market.

What are the key factors driving growth of the market?

Increasing number of R&D initiatives and increasing product launches, are expected to drive growth of the market.